OLOPATADINE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where OLOPATADINE was used for Psoriasis.
Most Reported Side Effects for OLOPATADINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Treatment failure | 4,685 | 53.3% | 0 | 1 |
| Drug ineffective | 1,600 | 18.2% | 0 | 8 |
| Eye irritation | 554 | 6.3% | 0 | 1 |
| Vision blurred | 368 | 4.2% | 0 | 1 |
| Eye pruritus | 317 | 3.6% | 0 | 4 |
| Hypersensitivity | 269 | 3.1% | 46 | 67 |
| Ocular hyperaemia | 260 | 3.0% | 1 | 2 |
| Eye pain | 228 | 2.6% | 0 | 1 |
| Eye discharge | 225 | 2.6% | 0 | 2 |
| Eye swelling | 143 | 1.6% | 0 | 3 |
| Dry eye | 132 | 1.5% | 0 | 0 |
| Lacrimation increased | 128 | 1.5% | 0 | 3 |
| Condition aggravated | 116 | 1.3% | 0 | 4 |
| Headache | 106 | 1.2% | 0 | 3 |
| Ocular discomfort | 95 | 1.1% | 0 | 0 |
Other Indications for OLOPATADINE
Product used for unknown indication (7,164)
Eye pruritus (396)
Eye allergy (344)
Conjunctivitis allergic (318)
Hypersensitivity (187)
Dry eye (94)
Ocular hyperaemia (89)
Pruritus (65)
Eye irritation (51)
Seasonal allergy (46)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)